View Scopus Profile

Edward W Greeno

Professor, Medicine - Hematology, Oncology, Transplant

Emailgreen048@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

6 Active
32 Finished

6 results

Filter

Active
An open-label, randomised, multicentre, phase III study of irinotecanliposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine insubjects who have not previously received chemotherapy for metastatic adenocarcinom
Greeno, E. W.
Ipsen Innovation
3/24/20 → 3/31/25
Project: Research project
A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced orMetastatic Biliary Tract Cancer
Greeno, E. W.
NUCANA, INC
12/12/19 → 12/31/24
Project: Research project
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and TolerabilityStudy of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Greeno, E. W.
Incyte Corporation
4/12/19 → 4/30/21
Project: Research project
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic AdenocarcinomaTRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer
Greeno, E. W.
ERYTECH PHARMA, INC
10/1/18 → 10/30/22
Project: Research project
Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies
Greeno, E. W.
Polaris Pharmaceuticals, Inc.
12/1/17 → 11/30/22
Project: Research project
A Phase 3, Randomized, Double-Blind, Placebo-Controlled,
Greeno, E. W.
HALOZYME, INC.
4/28/16 → 5/31/21
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.